<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>In 17 patients affected by atherosclerotic <z:e sem="disease" ids="C0042373" disease_type="Disease or Syndrome" abbrv="">vascular disease</z:e> and showing in basal conditions a hyperviscosity state, we have monitored the main hemorheological determinants during treatment with Suloctidil </plain></SENT>
<SENT sid="1" pm="."><plain>At the end of treatment carried out for 5 months the results showed that erythrocyte filterability was the only hemorheological determinant influenced </plain></SENT>
<SENT sid="2" pm="."><plain>The possible causes of this action are therefore considered </plain></SENT>
</text></document>